Haiteng Deng Selected Research

Dinoprostone (PGE2)

10/2022	Nicotinamide N-Methyltransferase Remodeled Cell Metabolism and Aggravated Proinflammatory Responses by Activating STAT3/IL1β/PGE2 Pathway.
1/2021	Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haiteng Deng Research Topics

Disease

37	Neoplasms (Cancer) 12/2023 - 08/2008
7	Infections 01/2023 - 04/2013
6	Inflammation (Inflammations) 02/2024 - 08/2008
6	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2013
6	Starvation 10/2023 - 04/2012
5	Multiple Myeloma 01/2020 - 06/2013
5	Ovarian Neoplasms (Ovarian Cancer) 06/2018 - 06/2013
4	Carcinogenesis 10/2021 - 05/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 01/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 11/2017
3	Obesity 01/2022 - 08/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 08/2020 - 01/2018
3	Necrosis 01/2018 - 01/2013
2	Fibrosis (Cirrhosis) 03/2023 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 10/2022 - 01/2020
2	Rheumatoid Arthritis 09/2021 - 10/2014
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2018
2	Myasthenia Gravis 03/2019 - 01/2019
2	Insulin Resistance 01/2019 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 01/2008
2	Hypoxia (Hypoxemia) 01/2018 - 10/2012
2	Pre-Eclampsia (Preeclampsia) 09/2016 - 05/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 01/2015
2	Tuberculosis (Tuberculoses) 07/2014 - 10/2009
1	IGA Glomerulonephritis (IGA Nephropathy) 03/2023
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2023
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Malaria 01/2023
1	DNA Virus Infections 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Disease Progression 11/2022
1	COVID-19 10/2022
1	Neoplasm Metastasis (Metastasis) 10/2022

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2013
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
7	EnzymesIBA 02/2024 - 11/2014
6	NAD (NADH)IBA 01/2022 - 08/2006
5	AntibodiesIBA 10/2022 - 10/2018
4	LipidsIBA 01/2023 - 09/2014
4	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2017
4	Lysine (L-Lysine)FDA Link 10/2022 - 01/2018
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2012
4	Cisplatin (Platino)FDA LinkGeneric 12/2017 - 11/2014
4	LigandsIBA 06/2016 - 08/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 11/2021
3	Histones (Histone)IBA 10/2023 - 01/2020
3	AlbuminsIBA 10/2022 - 01/2013
3	Nicotinamide MononucleotideIBA 01/2021 - 11/2020
3	UbiquitinIBA 01/2021 - 02/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2016 - 01/2015
2	ProstaglandinsIBA 02/2024 - 01/2021
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2024 - 01/2023
2	FlavonoidsIBA 12/2023 - 01/2022
2	Methionine (L-Methionine)FDA Link 06/2023 - 01/2021
2	Glutamine (L-Glutamine)FDA Link 06/2023 - 05/2013
2	Amino Acids FDA Link 06/2023 - 01/2023
2	RotenoneIBA 01/2023 - 06/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 10/2009
2	N-nitroso-N-methyltyramine (NNMT)IBA 10/2022 - 01/2022
2	Dinoprostone (PGE2)FDA Link 10/2022 - 01/2021
2	AntioxidantsIBA 01/2022 - 11/2014
2	AutoantibodiesIBA 09/2021 - 01/2018
2	ImmunosorbentsIBA 09/2021 - 01/2018
2	Chaperonin 60IBA 08/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	15-hydroxyprostaglandin dehydrogenaseIBA 01/2021 - 01/2018
2	Ligases (Synthetase)IBA 01/2021 - 05/2014
2	coactivator-associated arginine methyltransferase 1IBA 10/2020 - 10/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 07/2011
2	Cholinergic ReceptorsIBA 03/2019 - 01/2019
2	2,4- bis(N,N'- di(carboxymethyl)aminomethyl)fluoresceinIBA 03/2019 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2013
2	VimentinIBA 07/2016 - 11/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2016 - 02/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 08/2015
2	NitrogenIBA 04/2015 - 10/2012
2	AcidsIBA 05/2013 - 10/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2024
1	aluminum sulfate (alum)IBA 02/2024
1	Guanosine PentaphosphateIBA 06/2023
1	CarbohydratesIBA 01/2023
1	Interferon Type IIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	HMGN2 Protein (HMGN2)IBA 01/2023
1	Neutralizing AntibodiesIBA 10/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2022
1	Melanins (Melanin)IBA 10/2022
1	Protons (Proton)IBA 10/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2022
1	human ERBB2 proteinIBA 01/2022

Therapy/Procedure

9	Therapeutics 03/2023 - 11/2015
3	Drug Therapy (Chemotherapy) 01/2023 - 06/2013
2	Immunotherapy 01/2020 - 11/2018
1	Art Therapy 11/2022